BioMarin Pharmaceutical
LEI NSLL8ITTRR0J5HEMR848
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Profile
|
BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
|
General information
-
Organization nameBioMarin Pharmaceutical Inc.
-
Organization statusOperating organization
-
Address105 Digital Drive Novato, USA, 94949
-
Site
News
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Stocks
General information
-
Organization nameBioMarin Pharmaceutical Inc.
-
Organization statusOperating organization
-
Address105 Digital Drive Novato, USA, 94949
-
Site
Codes
-
LEINSLL8ITTRR0J5HEMR848
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
NACE*** ***
-
NAICS*** ***
-
CIK0001048477
-
EIN68-0397820









